Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

140,524 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results.
Qi C, Gong J, Li J, Liu D, Qin Y, Ge S, Zhang M, Peng Z, Zhou J, Cao Y, Zhang X, Lu Z, Lu M, Yuan J, Wang Z, Wang Y, Peng X, Gao H, Liu Z, Wang H, Yuan D, Xiao J, Ma H, Wang W, Li Z, Shen L. Qi C, et al. Among authors: wang h, wang w, wang z, wang y. Nat Med. 2022 Jun;28(6):1189-1198. doi: 10.1038/s41591-022-01800-8. Epub 2022 May 9. Nat Med. 2022. PMID: 35534566 Free PMC article. Clinical Trial.
Development of T cells carrying two complementary chimeric antigen receptors against glypican-3 and asialoglycoprotein receptor 1 for the treatment of hepatocellular carcinoma.
Chen C, Li K, Jiang H, Song F, Gao H, Pan X, Shi B, Bi Y, Wang H, Wang H, Li Z. Chen C, et al. Among authors: wang h. Cancer Immunol Immunother. 2017 Apr;66(4):475-489. doi: 10.1007/s00262-016-1949-8. Epub 2016 Dec 29. Cancer Immunol Immunother. 2017. PMID: 28035433 Free PMC article.
A novel BCMA CAR-T-cell therapy with optimized human scFv for treatment of relapsed/refractory multiple myeloma: results from phase I clinical trials.
Yang M, Zhang W, Yu K, Wang P, Jiang H, Chen L, Meng H, Weng Y, Tao R, Huang X, Xing C, Wang H, Wan J, Wang S, Dai L, Hendrix AY, Xiao J, Wang W, Ma H, Hao S, Jin J, Li Z, Jiang S. Yang M, et al. Among authors: wang h, wang w, wang p, wang s. Haematologica. 2022 Aug 1;107(8):1960-1965. doi: 10.3324/haematol.2022.280629. Haematologica. 2022. PMID: 35443566 Free PMC article. No abstract available.
Long term complete response of advanced hepatocellular carcinoma to glypican-3 specific chimeric antigen receptor T-Cells plus sorafenib, a case report.
Sun H, Xing C, Jiang S, Yu K, Dai S, Kong H, Jin Y, Shan Y, Yang W, Wang Z, Xiao J, Wang H, Wang W, Li Z, Shi K. Sun H, et al. Among authors: wang h, wang w, wang z. Front Immunol. 2022 Aug 17;13:963031. doi: 10.3389/fimmu.2022.963031. eCollection 2022. Front Immunol. 2022. PMID: 36059488 Free PMC article.
140,524 results
You have reached the last available page of results. Please see the User Guide for more information.